Literature DB >> 24425206

Expression of PPAR-γ in adipose tissue of rats with polycystic ovary syndrome induced by DHEA.

Yu-Xia Wang1, Wei-Jie Zhu2, Bao-Guo Xie1.   

Abstract

The objective of this study was to investigate the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ) in adipose tissue of the rat model of polycystic ovary syndrome (PCOS), induced by dehydroepiandrosterone (DHEA). Sixteen sexually immature Sprague-Dawley female rats were randomly assigned to the DHEA (n=8) or control (n=8) group. Adipose tissue was collected from the two rat groups following subcutaneous injection of DHEA in the DHEA group and a standard laboratory diet in the control group for 20 consecutive days. Reverse transcription polymerase chain reaction and western blot analysis were performed to detect expression of PPAR-γ at the mRNA and protein level in the adipose tissue. Both PPAR-γ mRNA and protein levels were decreased in the adipose tissue of DHEA‑induced PCOS rats compared to the control group. This decrease was significant (P<0.01). These results suggest that the pathogenesis of PCOS, which shares a number of common features with hyperandrogenemia, may involve the lipid metabolism pathway through inhibition of PPAR-γ.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24425206     DOI: 10.3892/mmr.2014.1895

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

2.  Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome.

Authors:  Trine Maxel; Pernille Fog Svendsen; Kamille Smidt; Jesper Krogh Lauridsen; Birgitte Brock; Steen Bønlykke Pedersen; Jørgen Rungby; Agnete Larsen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-02       Impact factor: 5.555

Review 3.  Ovarian Fibrosis: A Phenomenon of Concern.

Authors:  Feng Zhou; Li-Bing Shi; Song-Ying Zhang
Journal:  Chin Med J (Engl)       Date:  2017-02-05       Impact factor: 2.628

4.  Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation.

Authors:  Yun-Yun Shao; Zhuang-Peng Chang; Yao Cheng; Xin-Chun Wang; Jing-Ping Zhang; Xiao-Juan Feng; Yi-Ting Guo; Jun-Jin Liu; Rui-Gang Hou
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

5.  Therapeutic Effects of Eugenol in Polycystic Ovarian Rats Induced by Estradiol Valerate: A Histopathological and A Biochemical Study.

Authors:  Zahra Kokabiyan; Parichehreh Yaghmaei; Seyed Behnamedin Jameie; Zahra Hajebrahimi
Journal:  Int J Fertil Steril       Date:  2022-08-21

6.  Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway.

Authors:  Bin Jiang; Min Xue; Dabao Xu; Yujia Song; Shujuan Zhu
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.